Search

Author/Creator Desai, Monali

1. 2022-RA-687-ESGO ARTISTRY-7: phase 3, multicenter study of nemvaleukin alfa plus pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer (GOG-3063; ENGOT-OV68). (20th October 2022)

Authors:
Herzog, Thomas J; Moore, Kathleen; Konstantinopoulos, Panagiotis A; Gilbert, Lucy; Hays, John L; Monk, Bradley J; O'Malley, David M; Barlin, Joyce N; Graham, Julie R; Desai, Monali; Wang, Yan; Du, Yangchun; Dalal, Rita; Coleman, Robert L; Sehouli, Jalid
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 2
Page Start:
A255
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Online information discrepancies regarding safety of medicine use during pregnancy and lactation: an IMI ConcePTION study. Issue 9 (2nd September 2021)

Authors:
Nörby, Ulrika; Noël-Cuppers, Benedikte; Hristoskova, Sashka; Desai, Monali; Härmark, Linda; Steel, Michael; El-Haddad, Chantal; Douarin, Ludivine
Journal:
Expert opinion on drug safety
Issue:
Volume 20:Issue 9(2021)
Page Start:
1117
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. TP025/#1399 Artistry-7: phase 3 multicenter study of nemvaleukin alfa plus pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer. (4th December 2022)

Authors:
Herzog, Thomas; Hays, John; Moore, Kathleen; Konstantinopoulos, Panagiotis; Gilbert, Lucy; Monk, Bradley; O'Malley, David; Barlin, Joyce; Rege, Jessicca; Desai, Monali; Du, Yangchun; Dalal, Rita; Coleman, Robert L; Sehouli, Jalid
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 3
Page Start:
A235
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study. Issue 6 (June 2016)

Authors:
Stilgenbauer, Stephan; Eichhorst, Barbara; Schetelig, Johannes; Coutre, Steven; Seymour, John F; Munir, Talha; Puvvada, Soham D; Wendtner, Clemens-Martin; Roberts, Andrew W; Jurczak, Wojciech; Mulligan, Stephen P; Böttcher, Sebastian; Mobasher, Mehrdad; Zhu, Ming; Desai, Monali; Chyla, Brenda; Ve...
Journal:
Lancet oncology
Issue:
Volume 17:Issue 6(2016:Jun.)
Page Start:
768
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study. Issue 2 (February 2017)

Authors:
Seymour, John F; Ma, Shuo; Brander, Danielle M; Choi, Michael Y; Barrientos, Jacqueline; Davids, Matthew S; Anderson, Mary Ann; Beaven, Anne W; Rosen, Steven T; Tam, Constantine S; Prine, Betty; Agarwal, Suresh K; Munasinghe, Wijith; Zhu, Ming; Lash, L Leanne; Desai, Monali; Cerri, Elisa; Verdugo...
Journal:
Lancet oncology
Issue:
Volume 18:Issue 2(2017:Feb.)
Page Start:
230
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗